Prostate Cancer

Black Men Report More Regret Over Prostate Cancer Treatment Decisions

By

Natasha Persaud

Publish Date January 15, 2021

Mistrust and concerns about masculinity are important factors that influence Black men’s experience during prostate cancer management.

Use of Commercial Genomic Testing for Prostate Cancer ‘Highly Variable’ in the United States

By

Susan Jenks

Publish Date January 12, 2021

Investigators evaluated a large sample of commercially insured patients with prostate cancer to assess use of tissue-based gene expression testing.

Mediterranean Diet May Lower Prostate Cancer Progression Risk

By

Jody A. Charnow

Publish Date January 11, 2021

In a study of men on active surveillance for localized prostate cancer, each 1-unit increase in Mediterranean diet score, calculated based on patients’ baseline food frequency questionnaire information, was associated with a 12% decreased risk for Gleason grade group progression.

Orgovyx Now Available for Advanced Prostate Cancer

By

Brian Park, PharmD

Publish Date January 8, 2021

Orgovyx is an oral nonpeptide gonadotropin-releasing hormone (GnRH) receptor antagonist.

Salvage Therapies for Radiorecurrent Prostate Cancer Offer Similar RFS

By

Jody A. Charnow

Publish Date January 7, 2021

Investigators found no significant differences in 5-year RFS rates between RP and the other salvage modalities.

Prostate Cancer Resources

Clinical Trials

Drug Monographs

Fact Sheets